Literature DB >> 12795446

Small intestinal bacterial overgrowth: a possible risk factor for metabolic bone disease.

Abhinandana Anantharaju1, Michael Klamut.   

Abstract

Small intestinal bacterial overgrowth (SIBO) is one of the causes of malabsorption syndromes. The prevalence of metabolic bone disease in patients with SIBO is unknown, but a recent prospective case-control study indicated significant contribution of SIBO to the development of metabolic bone disease. We review this and other reports in the literature and discuss the possible mechanisms causing metabolic bone disease in patients with SIBO.

Entities:  

Mesh:

Year:  2003        PMID: 12795446     DOI: 10.1301/nr.2003.apr.132-135

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  2 in total

1.  Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test.

Authors:  Heiner K Berthold; Patrick Schober; Christian Scheurlen; Günter Marklein; Regine Horré; Ioanna Gouni-Berthold; Tilman Sauerbruch
Journal:  J Gastroenterol       Date:  2009-06-24       Impact factor: 7.527

2.  Probiotics ameliorate alveolar bone loss by regulating gut microbiota.

Authors:  Leming Jia; Ye Tu; Xiaoyue Jia; Qian Du; Xin Zheng; Quan Yuan; Liwei Zheng; Xuedong Zhou; Xin Xu
Journal:  Cell Prolif       Date:  2021-06-07       Impact factor: 6.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.